A qualitative study of the mental health outcomes in people being treated for obesity and type 2 diabetes with glucagon-like peptide-1 receptor agonists
Affiliation
Date
Publisher
Springer Science and Business Media LLC
Journal Title
Journal ISSN
Volume Title
Abstract
Abstract Objective Obesity and type 2 diabetes (T2D) are associated with increased rates of mental disorders, particularly depression, anxiety and binge-eating disorder. GLP-1 receptor agonists are a novel class of pharmacological agents for obesity and T2D. We aimed to describe participants’ experiences of GLP-1 receptor agonists on their mental health....